NCT01695434

A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months

A Prospective, Observational, Single-blinded, Longitudinal MRI Study of Effect of Glatiramer Acetate on Iron Deposition in Patients With Relapsing-remitting Multiple Sclerosis Over 24 Months

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 60 (actual)
• Sponsor: University at Buffalo · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

To explore whether treatment with glatiramer acetate (GA) may decrease iron deposition in subcortical deep GM, as detected by SWI-filtered phase imaging, in patients with RRMS over 24 months and compared to a reference population of healthy controls.

Detailed description

This is a prospective, observational, single-blinded, longitudinal, 24-month MRI study of the evolution of iron deposits, as evidenced by SWI-filtered phase imaging, in RRMS patients treated with GA and in healthy controls.

Conditions

• Multiple Sclerosis

Interventions

Type	Name	Description
OTHER	MRI	All subjects will undergo a MRI.

Timeline

• Start date: 2012-06-01
• Primary completion: 2013-02-01
• Completion: 2013-02-01
• First posted: 2012-09-28
• Last updated: 2013-03-25

Locations

1 site across 1 country: United States